Joint NTMnet/ESGMYC/TBnet webinar “M. abscessus pulmonary disease: from bench to bedside” on November 26, 2026
Dear Colleagues,
We invite you to join us on November 26 at 16:00 CET for a joint NTMnet/ESGMYC/TBnet webinar on “M. abscessus pulmonary disease: from bench to bedside". We look forward to your participation!
To join the webinar, please register in advance using the link below:
After registering, you will receive a confirmation e-mail containing information about joining the webinar.
Contact information: admin@tbnet.eu
Speakers:
PD Dr. Lucas Boeck is a clinician-scientist and research group leader in pulmonary infection biology at the University of Basel and University Hospital Basel, Switzerland. Following clinical training in internal and respiratory medicine, he undertook postdoctoral research at the Wellcome Sanger Institute and the MRC Laboratory of Molecular Biology in Cambridge, UK. Operating at the interface of fundamental biology and patient care, he seeks to change how antibiotic responses are measured and translated to improve infection therapy.
Talk: From single cells to clinical outcomes: Understanding antibiotic tolerance in M. abscessus
Prof. Dr. Jakko van Ingen is Professor of Diagnostics and Antimicrobial Therapy of Mycobacterial Infections at Radboud University Medical Center in Nijmegen, the Netherlands, where he leads the mycobacteriology reference laboratory. An internationally recognised expert in mycobacterial diseases, his research focuses on the pharmacodynamics of antimycobacterial drugs and the development of improved treatment regimens for tuberculosis and nontuberculous mycobacterial infections.
Talk: Results from the NTMnet survey on preferred regimens for M. abscessus disease
Chairs:
PD Dr. Nils Wetzstein is a consultant for infectious diseases at University Hospital Frankfurt (UHF). He has a keen interest in mycobacterial diseases and his research is primarily focused on NTM infections. The working group on mycobacterial diseases at UHF uses a variety of bacteriological, epidemiological and bioinformatical methods to improve clinical management and patient care for MTB and NTM infected patients.
PD Dr. sc. Onya Opota heads the Laboratory of Molecular Diagnostics, Mycobacteria, and Biosafety at the Institute of Microbiology, University of Lausanne, Switzerland. He combines routine diagnostic work and teaching with applied and translational research in molecular diagnostics for tuberculosis and nontuberculous mycobacterial infections. He holds a PhD in Life Sciences from the University of Nice Sophia Antipolis, France, and is board-certified in clinical microbiology following FAMH training in laboratory medicine.
Comments